Related references
Note: Only part of the references are listed.Waiting for PARIS-A Biological Target in Search of a Drug PARIS farnesylation: Considerations in addressing a new biological target for neuroprotection in patients with Parkinson's disease
Richard K. Wyse et al.
JOURNAL OF PARKINSONS DISEASE (2022)
Monoaminergic hypo- or hyperfunction in adolescent and adult attention-deficit hyperactivity disorder?
Susanne Nikolaus et al.
REVIEWS IN THE NEUROSCIENCES (2022)
Association of Attention-Deficit/Hyperactivity Disorder With E-Cigarette Use
Guifeng Xu et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2021)
Participation of glutamatergic and nitrergic systems in the striatal dopamine release induced by isatin, a MAO inhibitor
Lilian R. F. Faro et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
Systematic Review and Meta-Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder
Dimy Fluyau et al.
AMERICAN JOURNAL ON ADDICTIONS (2021)
Prolonging the Reduction of Nicotine Self-Administration in Rats by Coadministering Chronic Nicotine With Amitifadine, a Triple Monoamine Reuptake Inhibitor With CYP2B6 Inhibitory Actions
Edward D. Levin et al.
NICOTINE & TOBACCO RESEARCH (2020)
Early Substance Use in the Pathway From Childhood Attention-Deficit/Hyperactivity Disorder (ADHD) to Young Adult Substance Use: Evidence of Statistical Mediation and Substance Specificity
Andrea L. Howard et al.
PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2020)
Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation
Niall Mortimer et al.
NEUROPHARMACOLOGY (2019)
Monoamine oxidase inhibitory activity of flavoured e-cigarette liquids
Penelope Truman et al.
NEUROTOXICOLOGY (2019)
Causal Factors of Increased Smoking in ADHD: A Systematic Review
Jan van Amsterdam et al.
SUBSTANCE USE & MISUSE (2018)
Evaluating oral flavorant effects on nicotine self-administration behavior and phasic dopamine signaling
Robert J. Wickham et al.
NEUROPHARMACOLOGY (2018)
Menthol facilitates dopamine-releasing effect of nicotine in rat nucleus accumbens
Meiyu Zhang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2018)
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
Zachary Munn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
The Co-Occurrence of ADHD and Substance Use Disorders
Timothy E. Wilens et al.
PSYCHIATRIC ANNALS (2018)
Associations of ADHD Symptoms With Smoking and Alternative Tobacco Product Use Initiation During Adolescence
Nicholas Goldenson et al.
JOURNAL OF PEDIATRIC PSYCHOLOGY (2018)
ADHD in children and young people: prevalence, care pathways, and service provision
Kapil Sayal et al.
LANCET PSYCHIATRY (2018)
Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents
Marco Di Nicola et al.
FRONTIERS IN PSYCHIATRY (2017)
Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence
Ron C. Hogg
NICOTINE & TOBACCO RESEARCH (2016)
Effect of adult attention deficit hyperactivity symptoms on smoking cessation
Ceyhan Balci Sengul et al.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY (2016)
Effects and mechanism of action of isatin, a MAO inhibitor, on in vivo striatal dopamine release
Lorenzo Antonio Justo et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine
Tracy T. Smith et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
John P. M. Finberg et al.
FRONTIERS IN PHARMACOLOGY (2016)
Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells
David S. Goldstein et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson's Disease
Youssef Sari et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain
Joanna S. Fowler et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Stimulant Treatment of ADHD and Cigarette Smoking: A Meta-Analysis
Erin N. Schoenfelder et al.
PEDIATRICS (2014)
The Effects of Nicotine and Tobacco Particulate Matter on Dopamine Uptake in the Rat Brain
Kirsty Danielson et al.
SYNAPSE (2014)
A comprehensive assessment of memory, delay aversion, timing, inhibition, decision making and variability in attention deficit hyperactivity disorder: advancing beyond the three-pathway models
D. R. Coghill et al.
PSYCHOLOGICAL MEDICINE (2014)
Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder
Annabeth P. Groenman et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
Do Stimulants Reduce the Risk for Cigarette Smoking in Youth with Attention-Deficit Hyperactivity Disorder? A Prospective, Long-Term, Open-Label Study of Extended-Release Methylphenidate
Paul Hammerness et al.
JOURNAL OF PEDIATRICS (2013)
Stimulant Medication and Substance Use Outcomes A Meta-analysis
Kathryn L. Humphreys et al.
JAMA PSYCHIATRY (2013)
Modulations of brain amines and dopaminergic behavior by a novel, reversible and selective MAO-B inhibitor
Nibha Mishra et al.
BRAIN RESEARCH (2012)
Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis
Jing Wu et al.
MOLECULAR NEUROBIOLOGY (2012)
Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type
Amy J. Lewis et al.
TOBACCO CONTROL (2012)
The Effects of Childhood ADHD Symptoms on Early-onset Substance Use: A Swedish Twin Study
Zheng Chang et al.
JOURNAL OF ABNORMAL CHILD PSYCHOLOGY (2012)
Smoking, nicotine and neuropsychiatric disorders
Peter Dome et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Substance use in severe mental illness: self-medication and vulnerability factors
Jacopo Vittoriano Bizzarri et al.
PSYCHIATRY RESEARCH (2009)
Research Review: Dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD
Gail Tripp et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2008)
Further evidence of dopamine transporter dysregulation in ADHD: A controlled PET imaging study using altropane
Thomas J. Spencer et al.
BIOLOGICAL PSYCHIATRY (2007)
Tranylcypromine enhancement of nicotine self-administration
Anne-Sophie Villegier et al.
NEUROPHARMACOLOGY (2007)
Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD
Timothy E. Wilens et al.
AMERICAN JOURNAL ON ADDICTIONS (2007)
Placebo-controlled study examining effects of selegiline in children with attention-deficit/hyperactivity disorder
Suzanne Rubinstein et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2006)
Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder
AS Potter et al.
PSYCHOPHARMACOLOGY (2004)
Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial
S Akhondzadeh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Share Paper
